Anil Kulku

Anil Kulku

Active Director Director DIN 09103843
DIN 09103843 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Anil Kulku

Data last updated:

Anil Kulku is a Director at Manchester Lifesciences Private Limited (since 2021). The company operates in Chemicals. Manchester Lifesciences Private Limited reported revenue of ₹13.5 Lakh (FY 2022).

DIN 09103843
Primary Designation Director
Industry Chemicals
First Appointment 15 Mar 2021
Oldest Company Age 10 yrs
Largest company Manchester Lifesciences Private Limited · ₹13.5 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20212016₹13.5 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
Manchester Lifesciences Private Limited
Premium access

Shareholding and investment profile for Anil Kulku

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kulku

Anil Kulku currently holds 1 directorship: Manchester Lifesciences Private Limited (Director, since 15 Mar 2021, revenue ₹13.5 Lakh (FY 2022)).

Anil Kulku was first appointed on 15 Mar 2021 as Director at Manchester Lifesciences Private Limited.

The current boards of Anil Kulku's companies include Keethol Soumya (Manchester Lifesciences Private Limited), Pallayil Divakaran Nair (Manchester Lifesciences Private Limited), Unmesh Shrikant Jere (Manchester Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available